Announcement 03.04.20 Share on Twitter Share on Facebook Share on LinkedIn 2019 Annual Report From Start – to Cancer is Finished. Sean Parker’s vision for the Parker Institute for Cancer Immunotherapy (PICI) has been clear from the beginning: bring the top researchers together, give them everything they need to pursue and push their best ideas forward and eliminate the barriers in their way. In just over three years, we’ve been hard at work, putting that vision into action. We work hand-in-hand with our network and experts across the field to supercharge scientific discoveries that answer the fundamental questions in cancer immunotherapy. We launch and manage novel clinical trials with the goal of getting the best treatments to patients. We build systems that aggregate and process data – making every initiative more informed than the last and providing direction for where to go next. And we invest in emerging companies with bold ideas and work with industry partners to help us propel our research. In short, we’re transforming the way cancer research is done to save lives. Faster. Our progress speaks for itself. Take a look at our report to see what we’ve achieved over the past year. Read our 2019 Annual Report Related Cancer Research Heroes, Our Impact, Press Release PICI Awards $2.75 Million Six Early Career Researchers Our Impact, Press Release, Research Update For Advanced Pancreatic Cancer, Combining Immunotherapies with Chemotherapy Shows Early Promise in Reducing Tumor Size Our Impact PICI BioTrust Decodes Triple Negative Breast Cancer Partner Highlight Nonprofits Join Forces for a Cure Cancer Research Heroes A Visionary Paving the Way for Faster Cures Research Update Brain Cancer Breakthrough with Immunotherapy Points to New Hope for Patients
Cancer Research Heroes, Our Impact, Press Release PICI Awards $2.75 Million Six Early Career Researchers
Our Impact, Press Release, Research Update For Advanced Pancreatic Cancer, Combining Immunotherapies with Chemotherapy Shows Early Promise in Reducing Tumor Size